The role of nitric oxide in the control by the vagal nerves of the heart of the ferret

Experimental Physiology

Volumn 83, Issue 4, 1998, Pages 469-480

  Conlon, Kelly ^a   Collins, Tanya ^a   Kidd, Cecil ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CHRONOTROPISM; CONTROLLED STUDY; FERRET; HEART INNERVATION; HEART RATE; MEAN ARTERIAL PRESSURE; NERVE STIMULATION; NONHUMAN; PARASYMPATHETIC INNERVATION; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 0031901209     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/expphysiol.1998.sp004130     Document Type: Article

References (24)

1. BALLIGAND, J. L., KELLY, R. A., MARSDEN, P. A., SMITH, T. W. & MICHEL, T. (1993). Control of cardiac muscle cell function by anendogenous nitric oxide signalling system. Proceedings of the National Academy of Sciences of the USA 90, 347-351.
2. BRADY, A. J. B., WARREN, J. B., POOLE-WILSON, P. A., WILLIAMS, T. J. & HARDING S. E. (1993). Nitric oxide attenuates cardiac myocyte contraction. American Journal of Physiology 265, H176-182.
3. BOHN, H., BRENDEL, J., MARTORANA, P. A. & SCHONAFINGER, K. (1995). Cardiovascular actions of the furoxan CAS 1609, a novel NO donor. British Journal of Pharmacology 114, 1605-1612.
4. G-nitro-L-arginine methyl ester and other alkyl esters are muscarinic receptor antagonists. Circulation Research 72, 387-395.
5. CONLON, K., COLLINS, T. & KIDD, C. (1996). Modulation of vagal actions on heart rate produced by inhibition of nitric oxide synthase in the anaesthetized ferret. Experimental Physiology 81, 547-550.
6. CONLON, K., COLLINS, T. & KIDD. C. (1997a) Modulation of vagally induced changes in cardiac atrio-ventricular conduction by nitric oxide in the anaesthetized ferret. Journal of Physiology 501.P, 70P.
7. CONLON, K., COLLINS, T. & KIDD, C. (1997b). Further evidence for nitric oxide modulation of vagal bradycardia in the anaethetized ferret. Journal of Physiology 501.P, 70P.
8. CONLON, K., COLLINS, T. & KIDD, C. (1997c). The neuronal NOS inhibitors, TRIM, attenuate vagal chronotropic and dromotropic actions in the anaesthetized ferret. Journal of Physiology 504.P, 37-38P.
9. ELVAN, A., RUBART, M. & ZIPES, D. P. (1997). NO modulates autonomie effects on sinus discharge rate and AV nodal conduction in open chest dogs. American Journal of Physiology 272, H263-271.
10. HAN, X., SHIMONI, Y. & GILES, W. R. (1994). An obligatory role for nitric oxide in the autonomic control of heart rate. Journal of Physiology 476, 309-314.
11. HARE, J. M. & COLUCCI, W. S. (1995). Role of nitric oxide in the regulation of myocardial function. Progress in Cardiovascular Diseases 38, 155-166.
12. HARE, J. M., LOH, E., CREAGER, M. A. & COLUCCI, W. S. (1995). Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation 92, 2198-2203.
13. IGNARRO, L. J. (1991). Signal transduction mechanisms involving NO. Journal of Pharmacology 41, 485-490.
14. KENNEDY, R. H., HICKS, K. K., BRIAN, J. E. & SEIFEN, E. (1994). NO has no chronotropic effect in right atria isolated from rat heart. European Journal of Pharmacology 255, 149-156.
15. KLABUNDE, R. E., RITGER, R. C. & HELGREN, M. C. (1991). Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (NO) formation / release in anaesthetised dogs. European Journal of Pharmacology 199, 51-59.
16. KLATT, P., SCHMIDT, K., BRUNNER, F. & MAYER, B. (1994). Inhibitions of brain nitric oxide synthase, binding kinetics, metabolism and enzyme inactivation. Journal of Biological Chemistry 269, 1674-1680.
17. LEFER, A. M. & MUROHARA, T. (1995). Comparative pharmacology of nitric oxide and nitric oxide generators on cardiac contractility in mammalian species. International Journal of Cardiology 50, 239-242.
18. MAZGALEV, T, DREIFUS, L. S., MICHELSON, E. L. & PELLEG, A. (1986). Effect of postganglionic vagal stimulation on the organisation of atrioventricular nodal conduction in isolated rabbit heart tissue. Circulation 74, 869-880.
19. MOHAN, P., SYS, S. U. & BRUTSAERT, D. L. (1995). Positive inotropic effect of nitric oxide in myocardium. International Journal of Cardiology 50, 233-237.
20. MONCADA, S., PALMER, R. J. S. & HIGGS, E. A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews 43, 109-142.
21. MOORE, P. K. & HANDY, R. L. C. (1997) Selective inhibitors of neuronal nitric oxide synthase - is no NOS really good NOS for the nervous system? Trends in Pharmacological Sciences 18, 204-211.
22. REES, D., PALMER, R. M., SCHULZ, R., HUDSON, R. F. & MONCADA, S. (1990). Characterisation of 3 inhibitors of endotheliul nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology 101, 746-752.
23. SHAH, A. M., PRENDERGAST, B. D., GROCOTT-MASON, R., LEWIS, M. J. & PAULUS, W. J. (1995). The influence of endothelium derived nitric oxide on myocardial contractile function. International Journal of Cardiology 50, 225-231.
24. WEYRICH, A. S., MA, X. L., BUERKE, M., MUROHARA, T., ARMSTEAD, V. E., LEFER, A. M., NICOLAS, J. M., THOMAS, A. P., LEFER, D. J. & VINTEN-JOHANSEN, J. (1994). Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulatcd cardiac muscle. Circulation Research 75, 692-700.